跳至主要内容
临床试验/jRCT2080225039
jRCT2080225039已完成3 期

Cross-over study of PDLYMT in chronic kidney disease (CKD) patients undergoing hemodialysis therapy

NIPRO CORPORATION1 个研究点目标入组 52 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
52
试验地点
1
主要终点
-

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
干预模型
A Multicenter, Two-treatment Cross-over Study
主要目的
Treatment Purpose

入排标准

年龄范围
20age old over 至 84age old under(—)
性别
All

入选标准

  • Patients providing written informed consent about participation in this clinical study
  • Patients aged 20 to 84 years old at the time of informed consent

排除标准

  • Patients within 3 months of initiating hemodialysis at the time of informed consent
  • Patients who find it difficult to undergo HD stably during the entire duration of this study
  • Patients who are pregnant or who have the possibility of pregnancy at the time of informed consent
  • Patients participating in clinical studies of other drugs, medical devices, etc. at the time of informed consent for this study
  • Patients who may not be able to be evaluated as described in the protocol due to serious disease
  • Patients judged by the investigator or sub-investigator to be inadequate for this study

结局指标

主要结局

-

efficacy confirmatory [Efficacy] Reduction ratio

次要结局

未报告次要终点

研究者

研究点 (1)

Loading locations...

相似试验

Cross-over study of PDLYMT in chronic kidney disease... | 临床试验